Gassy you're confusing yourself and reading what you want to believe.
ANP is addressing the PDCO information requirements and anticipates finalising the trial design with PDCOlater in Q3’CY21,
AHEADof submitting the clinical trial application shortly thereafter for the Phase IIb trial of ATL1102 in non-ambulant DMD patients to be conducted in Europe.
- Forums
- ASX - By Stock
- PER
- Where others have failed will Atl1102 succeed ?
Where others have failed will Atl1102 succeed ?, page-411
-
- There are more pages in this discussion • 686 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
|
|||||
Last
8.3¢ |
Change
-0.002(2.35%) |
Mkt cap ! $74.82M |
Open | High | Low | Value | Volume |
8.3¢ | 8.4¢ | 8.3¢ | $33.95K | 407.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 12164 | 8.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.4¢ | 1366 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 12164 | 0.082 |
2 | 143500 | 0.081 |
2 | 106250 | 0.080 |
3 | 132078 | 0.079 |
2 | 120924 | 0.078 |
Price($) | Vol. | No. |
---|---|---|
0.084 | 1366 | 1 |
0.085 | 136669 | 3 |
0.086 | 27375 | 1 |
0.087 | 429525 | 2 |
0.088 | 457142 | 2 |
Last trade - 15.57pm 03/09/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |